For decades, confirming Alzheimer’s disease meant PET scans, spinal taps or waiting until symptoms became severe enough to leave little doubt. That is beginning to change. Two FDA-cleared blood tests ...
Nearly 7 million Americans are living with Alzheimer's disease and that number is projected to rise to nearly 13 million.
"By bringing Alzheimer's blood-based biomarker testing into primary care, we can help patients and their clinicians get answers sooner." ...